We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
UGI
UGI
$8B
| $43.8K | ﹤0.01% |
1,268
+397
| +46% | +$14K |
|
1452
Vaxcyte
PCVX
$7.89B
| $43.8K | ﹤0.01% |
753
-95
| -11% | -$5.16K |
|
1453
J.M. Smucker
SJM
$12.6B
| $43.8K | ﹤0.01% |
389
+21
| +6% | +$2.14K |
|
1454
Omnicell
OMCL
$1.86B
| $43.7K | ﹤0.01% |
1,053
+294
| +39% | +$11.9K |
|
1455
OneSpan
OSPN
$562M
| $43.7K | ﹤0.01% |
3,043
+410
| +16% | +$5.18K |
|
1456
Griffon
GFF
$4.16B
| $43.6K | ﹤0.01% |
447
-44
| -9% | -$3.84K |
|
1457
ProPetro Holding
PUMP
$1.45B
| $43.6K | ﹤0.01% |
3,040
| – | – |
|
1458
Sotera Health
SHC
$4.95B
| $43.6K | ﹤0.01% |
2,454
-215
| -8% | -$3.39K |
|
1459
Equitable Holdings
EQH
$13.1B
| $43.5K | ﹤0.01% |
992
+74
| +8% | +$3.09K |
|
1460
Broadstone Net Lease
BNL
$4.29B
| $43.5K | ﹤0.01% |
2,103
| – | – |
|
1461
Bank of Marin Bancorp
BMRC
$466M
| $43.4K | ﹤0.01% |
1,567
| – | – |
|
1462
JPMorgan Ultra-Short Income ETF
JPST
$40B
| $43.4K | ﹤0.01% |
858
| – | – |
|
1463
Cactus
WHD
$3.83B
| $43.3K | ﹤0.01% |
846
| – | – |
|
1464
Orrstown Financial Services
ORRF
$836M
| $43.3K | ﹤0.01% |
1,061
+223
| +27% | +$8.41K |
|
|
MZTI
1465
The Marzetti Company
MZTI
$2.94B
| $43.2K | ﹤0.01% |
378
+309
| +448% | +$37.2K |
|
1466
Metallus
MTUS
$873M
| $43.1K | ﹤0.01% |
2,308
+39
| +2% | +$732 |
|
1467
WisdomTree US High Dividend Fund
DHS
$1.56B
| $43.1K | ﹤0.01% |
+379
| New | +$42.2K |
|
1468
Ziff Davis
ZD
$1.9B
| $43.1K | ﹤0.01% |
823
+121
| +17% | +$5.47K |
|
1469
Napco Security Technologies
NSSC
$1.28B
| $43K | ﹤0.01% |
1,131
-14
| -1% | -$556 |
|
1470
Greif
GEF
$4.47B
| $42.9K | ﹤0.01% |
576
+101
| +21% | +$6.78K |
|
1471
Inspire Medical Systems
INSP
$1.42B
| $42.7K | ﹤0.01% |
958
+758
| +379% | +$35.9K |
|
1472
Dime Commercial Bancshares
DCOM
$1.75B
| $42.7K | ﹤0.01% |
1,051
| – | – |
|
1473
Live Oak Bancshares
LOB
$1.95B
| $42.7K | ﹤0.01% |
1,046
| – | – |
|
1474
First Business Financial Services
FBIZ
$562M
| $42.7K | ﹤0.01% |
676
| – | – |
|
1475
National Beverage
FIZZ
$2.87B
| $42.6K | ﹤0.01% |
1,367
+871
| +176% | +$30.4K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.